pre-seed
Stage
2022
Founded
1
Investors
About
Pacifico BioLabs is a biotech company developing novel small molecule therapeutics for autoimmune diseases. Their lead program targets a new mechanism in inflammatory bowel disease (IBD).
Explore Pacifico BioLabs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.